IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade Commission…
Geschäftstreiber: Edward Lifesciences (EW) gehört zu den führenden Anbietern im Bereich Medizintechnik. Stark aufgestellt ist man vor allem bei Herzklappen,…
Edwards Lifesciences stock reaches 52-week high at 81.86 USD…
Edwards Lifesciences posts a second-quarter 2025 earnings and revenue beat, with strong growth in TAVR and TMTT segments despite margin…
The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended June 2025,…
Edwards Lifesciences shares leap 7% on strong Q2 results, sales growth guidance…
…
Edwards Lifesciences stock rises following competitor’s exit…
Edwards Lifesciences first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat patients with structural heart disease.…
The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended March 2025,…
Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended March 2025, looking beyond the conventional Wall Street…
Edwards Lifesciences SWOT analysis: stock faces TAVR headwinds, TMTT potential…
Edwards Lifesciences reports strong contributions from all product groups ??? TAVR, TTMT and surgical structural heart ??? in the fourth…
Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter…
Stifel raises Edwards Lifesciences stock to buy, target to $90…
Edwards Lifesciences exec sells $343,735 in stock…
Edward Lifesciences robust potential in Structural heart and long-term strategy instill optimism.…
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline…
NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
SAN DIEGO, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…
Die Edwards Lifesciences Aktie verzeichnete am 2. November 2024 einen erneuten Anstieg und setzte damit ihren positiven Trend der letzten…
Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
…
Edelson Lechtzin LLP announces the filing of a securities fraud class action on behalf of all purchasers of Edwards Lifesciences…
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
SAN DIEGO, Oct. 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Should Contact Bernstein Liebhard LLP…
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…
Edward Lifesciences Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.…
Die Edwards Lifesciences Aktie verzeichnete am 21. September 2024 einen leichten Rückgang von 0,57% auf 66,84 USD. Trotz dieses kleinen…
…
BDX expands its smart care portfolio by acquiring Edwards Lifesciences Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven…
Edward Lifesciences (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.…
Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.…
After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more…
The company now expects full-year sales in its TAVR division to climb 5% to 7%.…
Edwards Lifesciences (EW) exercises the option to acquire Innovalve Bio-Medical Ltd., strengthening its TMVR technology portfolio and addressing unmet…
Edwards Lifesciences (EW) TMTT segments PASCAL platform is likely to have maintained strong growth momentum in the second quarter…
…
Wenig Kursbewegung aktuell bei dem Anteilsschein von Edwards Lifesciences . Das Papier kostete zuletzt 91,47 US-Dollar. Die Wertschätzung der Investoren…
…